Reply to Calvin Pan.

[1]  C. Pan.  The role of earlier use of immunoprophylaxis in preventing mother to child transmission of hepatitis B. , 2020, Clinical Infectious Diseases.

[2]  Biao Xu,et al.  Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Hong‐Lin Chen,et al.  Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: A systematic review and a meta-analysis. , 2019, Midwifery.

[4]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[5]  Z. Wang,et al.  Safety and efficacy of telbivudine in late pregnancy to prevent mother‐to‐child transmission of hepatitis B virus: A multicenter prospective cohort study , 2018, Journal of viral hepatitis.

[6]  Noele P. Nelson,et al.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B , 2018, The New England journal of medicine.

[7]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[8]  Yali Hu,et al.  Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus , 2013, BMC Pregnancy and Childbirth.

[9]  S. Locarnini,et al.  Perinatal transmission of hepatitis B virus: an Australian experience , 2009, The Medical journal of Australia.

[10]  J. Brok,et al.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis , 2006, BMJ : British Medical Journal.